Abstract
Keywords
Scrophularia atropatana Phytochemical analysis Biological activities GC-MS analysis MTT assay
Introduction
Malignant neoplastic cancer is regarded as one of the most common chronic diseases worldwide and is responsible for several deaths annually (according to a WHO report). Many cancerous patients are resistant to common and conventional strategies such as surgical removal, radiotherapy as well as chemotherapy approaches. Conversely, the serious side effects and patient complications of the aforementioned methods have encouraged scientists to discover new methods and therapeutic drugs for increasing the quality of life, survival rate, and preventing side effects. Since ancient time, natural compounds as complementary sources have been of major interest for various diseases such as cancer (1-3). Hence, many natural products such as vincristine, vinblastine, and others, as potential novel anti-tumor agents, have been isolated from herbal sources or other related sources. Moreover, herbal remedies illustrate acceptable anti-proliferative activities on cancerous cells without causing unfavorable effects on the normal cells. For instance, one of these herbs which should be noted is Scrophularia atropatana (S. atropatana) L. This plant is an important member of the Scrophulariaceae family, locally known as «gole meimuni ye Azari» and occurs mainly in Central Europe, Asia and North America, especially in the Mediterranean area (4, 5). Scrophularia genus is represented in the Iranian Flora by 42 species. Previous phytochemical reports on other species of Scrophularia have revealed that this genus is known to produce diverse natural compounds including iridoides, phenyl propanoides, flavonoids, saponins, and terpenoids. Other studies on the essential oil compositions of some species of this genus have demonstrated the presence of terpenoid structures, linear hydrocarbons, and their derivatives (4, 6). Hence, this genus because of its already mentioned major constituents, has been holding a place of value in herbology with some known medical properties such as anti-inflammatory, anti-bacterial, cardiovascular, diuretic, protozoacidal, fungicidal, cytotoxic, anti-nociceptive, and wound healing benefits (7-13). In continuation of our scientific works on the analysis of the volatile and non-volatile components of the different plants along with their biological activities (8, 14-19), no report was found on the phytochemicals of S. atropatana to date. Thus, we have now evaluated the volatile constituents along with the cytotoxic activity against cancerous and non-cancerous cells, from the aerial parts of the plant that is grown in the Azerbaijan province of Iran.
Experimental
Chemicals
3(4,5-dimethylthiazol-2-yl) 2,5-diphenyl-tetrazolium bromide (MTT; Sigma-Aldrich, USA); 2,2-diphenyl-1-picrylhydrazyl (DPPH), rutin, gallic acid, Folin-Ciocalteu reagent, Aluminum chloride, penicillin G-streptomycin and Fetal Bovine Serum (FBS) all from Sigma Aldrich (Germany), RPMI 1640 from Gibco, UK, Phosphate Buffer Saline (PBS), Muller Hinton Agar Medium (MERCK) and Trypsin–EDTA (Gibco, Paisley, UK) were purchased. All other reagents and chemicals were of analytical grade. Solvents used for extraction and tests purchased from Caledon and Scharlau. ELISA plate reader (BioTeck, Bad Friedrichshall, Germany) was used for anti-proliferative test. (DPPH) reagent (C18H12N5O6 formula, molecular weight 394) (Sigma-Aldrich, Germany), also were used in this paper.
Collection and identification of plant material
The chopped aerial parts of S. atropatana were gathered in May 2013, at altitudes above 1600 m from Spiran region in East Azerbaijan province. Voucher specimen after identifying (Tbz- fph- 8962) has been retained at the Herbarium of the Department of Pharmacognosy, Faculty of Pharmacy, Tabriz University of Medical Sciences, Iran.
Extraction and Fractionation
Powdered aerial parts of S. atropatana were extracted by Soxhlet to obtain n-hexane (n-hex), dichloromethane (DCM) and methanol (MeOH) extracts, successively. For further investigations, the potent extract (inhibited strongly growth of the malignant cells) was subjected to Vacuum Liquid Chromatography (VLC) method for fractionation (20-23). VLC is a method to obtain different fractions of non-polar extracts. In this method, first VLC hopper was connected to Buchner filter, and then a filter paper was put on the filter. In the next step, the silica gel was loaded into the 2/3 of the tightened hopper. Subsequently, the vacuum pomp was used to compact the silica gel. Another filter paper was placed on the silica gel column. After these preparations, 150 mL methanol, 150 mL ethyl acetate, and 150 mL 10% ethyl acetate (10% EtOAc and 90% n-hex) were passed over the silica gel, respectively. Then, the filter paper over the column was removed. Afterwards, DCM extract was solved in adequate 10% EtOAc in n-hex and then the solution was loaded over the column and then step by step several concentrations of EtOAc in n-hex (10%, 20%, 40%, 60%, 80% and 100%) were passed through the column and were collected in separate containers.
Moreover, the polar extracts which had high free radical scavenging activity and total phenolic contents were fractionated by Solid Phase Extraction (SPE) method. Two grams of MeOH extract was loaded on a Sep-pak (10 g: C18) cartridge (Waters, Ireland) and eluted by increasing step gradients of MeOH-water mixtures. For removing the solvents, Rotary evaporator (Heildolph, Schwabach, Germany) at a maximum temperature of 45 °C and in a low pressure was used. For further investigations, the samples were stored in a freezer at -20 °C.
Distillation of plant materials
Shed-dried plant material of the aerial parts of S. atropatana was subjected to hydro-distillation for 3 h using a Clevenger-type apparatus. Resulted essential oil (EO) was subsequently dehydrated using anhydrous sodium sulphate and kept at low temperature (4 °C) in dark until analysis.
Gas Chromatography-Mass Spectrometry (GC-MS) analysis and identification of compounds
The analysis of the EO and cytotoxic DCM extract and its potent fractions was performed using a Shimadzu GC-MS-QP5050A fitted with a fused DB-1 capillary column (methyl phenyl syloxane, 60 m, 0.25 mm id, film thickness 0.25 µm). Helium was used as a carrier gas at a flow rate of 1.3 mL/min, as well as split ratio 1.29. Temperatures of the injector and detector were set at 250 °C and 260 °C, respectively. The column temperature was kept at 50 °C for 2 min, and then programmed to increase to 230 °C at a rate of 2 °C/min and then kept constant for 8 min. The MS spectral parameters were as follows: ionization energy 70 eV; ion source temperature 200 °C; quadrupole 100 °C; solvent delay 3 min; EV voltage 3000 v. Qualitative identification of constituents was based on direct comparison of the retention indices, Kovats indices and Mass spectral with those for standard compounds and computer matching with the NIST NBS54K Library, as well as by comparison with published papers (4, 6). Flame ionization detector (FID) was used for calculating relative percentage amounts. The FID detector condition was set on the same GC-MS operational conditions.
Antimicrobial assay
In-vitro anti-microbial activity of all samples (n-hex, DCM, MeOH and EO) of S. atropatana was assessed against following organisms: Two strains of gram negative species, Pseudomonas aeroghinosa (ATCC 9027) and Escherichia coli (ATCC 8739), as well as the gram positive species namely Staphylococcus epidermidis (ATCC 12228) and Staphylococcus aureus (ATCC 6538), and a fungi (Candida albicans) (ATCC 10231) which were purchased from the institute of Pasture, Type Culture Collection (Iran). Agar disc diffusion method as the qualitative antibacterial assay was used for this aim. Cultured bacteria in to the Muller Hinton Broth was incubated at 37 °C for 24 h. Then, the centrifuged pellets re-suspended in saline solution to provide an optical density equal to 106 CFU/mL. Test organisms were cultured in a suitable Muller Hinton Agar Medium. Sterile 6.0 mm diameter discs were impregnated with 50 µL of different test substances. Subsequently, the plates for 30 min were kept in a refrigerator to allow the diffusion of extracts, and then they were incubated at 37 °C for 24 h. The quantitative antimicrobial potency of the samples was assessed by measuring the diameter of the inhibition zones in comparison to DMSO and Amikacin as a negative and positive control groups. All experiments were performed in duplicate and mean ± SD value was calculated (24).
Anti -proliferative activity
Malignant and nonmalignant cells including SW480 (colon carcinoma) MCF-7 cells (human breast carcinoma cell line) and L-929 (normal cell line) from Pasture Institute, Tehran, Iran were cultured in RPMI 1640 medium with suitable additives containing 10% Fetal Bovine Serum (FBS), 100 mg/mL streptomycin and 100 units/mL penicillin G. They were incubated at 37 °C in a humidified air/carbon dioxide (95:5) atmosphere. MTT colorimetric assay was used for assessing viability of the cells. The cells in the exponential growth stage were sub-cultured at 1 × 104/well on to 96-well plates (Nunc, Denmark). Then, the cell suspensions were treated with different dilutions of all extracts for 24 and 48 h. Four hours before the end of the time, the medium was replaced with a fresh culture containing 20 μL of MTT solution (5 mg/mL in PBS). Then after this period, the supernatants were removed and 100 µL of DMSO solvent was added to dissolve the formazan crystals completely. Finally, the absorbance of the metabolized MTT production (formazan crystals) was read at 570 nm with microplate reader (BioTeck, Bad Friedrichshall, and Germany). (BioTeck, Bad Friedrichshall, and Germany). The IC50 values were defined as the concentration of the samples required to induce a 50% reduction in viability of the cells absorbance and evaluated from a dose-response curve plotted in the SigmaPlot 11 software (25, 26). Methotrexate was used as positive control.
Free radical scavenging test, Total phenolic content, and total flavonoid content of n-hexane, dichloromethane and methanol extracts of S. atropatana aerial parts
Extracts or fractions | Total phenol content (mg g-1) | Flavonoid content (mg g-1) | Antioxidant activity (RC50; mg mL ) |
---|---|---|---|
MeOH* | 68.37 ± 0.06 | 52.04 ± 0.42 | 0.143 ± 0.09 |
DCM* | 27.29 ± 1.02 | - | 0.681 ± 0.02 |
n-hexane | 3.21 ± 0.30 | - | 0.576 ± 0.008 |
10% SPE fraction | 7.44 ± 0.20 | 5.60 ± 0.31 | 1.164 ± 0.20 |
20% SPE fraction | 42.54 ± 0.45 | 25.66 ± 0.33 | 0.092 ± 0.00 |
40% SPE fraction | 146.65 ± 2.34 | 120.12 ± 2.25 | 0.046 ± 0.00 |
60% SPE fraction | 127.52 ± 0.31 | 100.23 ± 4.43 | 0.102 ± 0.00 |
80% SPE fraction | 24.76 ± 0.32 | 14.23 ± 1.12 | 0.194 ± 0.02 |
100% SPE fraction | 4.76 ± 0.21 | 3.05 ± 0.01 | 0.534 ± 0.26 |
Results of the MTT assay of Vaccum Liquid chromatography fractions of potent Dichloromethane of S. atropatana aerial parts against cancer and normal cells
Samples | IC50 Values (µg/mL) | ||||
---|---|---|---|---|---|
MCF-7 | L929 | ||||
24 h | 48 h | 24 h | 48 h | ||
10% VLC | 123.7 ± 0.98 | 113.8 ± 43.7 | >500 | 220.00 ± 32.01 | |
20% VLC | 103.59 ± 17.83 | 94.3 ± 13.42 | >500 | 190.23 ± 15.45 | |
40% VLC | 247.5 ± 62.08 | 205.7 ± 39.88 | >500 | 300.00 ± 46.71 | |
60% VLC | 148.85 ± 31.60 | 208.05 ± 38.53 | >500 | 380.23 ± 49.22 | |
80% VLC | 98.105 ± 25.59 | 88.53 ± 12.85 | >500 | 230.45 ± 56.28 | |
100% VLC | 62.29 ± 4.29 | 60.7 ± 10.79 | >500 | 198.20 ± 43.25 | |
Methotrexate | 0.16 ± 0.09 (48 h) | 0.24 ± 0.01 (48 h) |
Chemical constituents of the essential oil from aerial parts of S. atropatana
Area (%) | RT (min) | KI(a) | Molucular formula | Compounds | Number | ||
---|---|---|---|---|---|---|---|
0.03 | 10.29 | 800 | C5H4O2 | Furfural | 1 | ||
0.03 | 16.40 | 912 | C6H12O | 2-Pentanone، 3-methyl | 2 | ||
0.01 | 18.42 | 941 | C6H14O | Isobutylmethylmethanol | 3 | ||
0.12 | 19.02 | 950 | C7H14 | Cyclopropane،1،1،2،3-tetramethyl | 4 | ||
0.02 | 19.12 | 952 | C7H14 | -1Pentene، 2،4-dimethyl | 5 | ||
0.14 | 19.23 | 953 | C7H12O | -1Hepten-3-one | 6 | ||
0.23 | 19.80 | 962 | C8H16O | -1Octen-3-ol | 7 | ||
0.02 | 20.85 | 977 | C9H14O | 2-Pentylfuran | 8 | ||
0.15 | 20.96 | 979 | C8H16O | Cyclooctyl alcohol | 9 | ||
0.10 | 22.83 | 1006 | C8H8O | Benzeneacetaldehyde | 10 | ||
0.03 | 24.35 | 1026 | C10H16 | beta.-trans-Ocimene | 11 | ||
0.08 | 25.17 | 1037 | C10H16 | beta.-cis-Ocimene | 12 | ||
0.09 | 26.41 | 1054 | C10H20 | 1-Octene،3،7-dimethyl | 13 | ||
0.03 | 28.16 | 1077 | C10H16 | α- Terpinolen | 14 | ||
2.14 | 28.51 | 1082 | C9H18O | Nonanal | 15 | ||
18.82 | 28.87 | 1087 | C10H18O | Linalool | 16 | ||
0.28 | 32.35 | 1133 | C10H18O | 2-Decenal، (E) | 17 | ||
0.20 | 34.04 | 1156 | C10H22O | 1-Decanol | 18 | ||
0.20 | 34.30 | 1159 | C10H18O | 1-Terpinen-4-ol | 19 | ||
4.14 | 35.19 | 1171 | C10H18O | alpha.-Terpineol | 20 | ||
0.54 | 36.14 | 1184 | C10H20O | Capraldehyde | 21 | ||
0.13 | 36.46 | 1188 | C10H16O | Carvomenthenal | 22 | ||
0.13 | 36.87 | 1194 | C10H16O | beta-cyclocitrat | 23 | ||
1.57 | 38.03 | 1209 | C10H18O | cis-Geraniol | 24 | ||
5.68 | 39.91 | 1235 | C10H18O | 1،6-octadien-3-ol،3،7-dimethyl | 25 | ||
0.26 | 41.65 | 1259 | C9H18O2 | 3-Ethylheptanoic acid | 26 | ||
0.33 | 41.78 | 1261 | C9H18O2 | Nonanoic acid | 27 | ||
0.15 | 42.21 | 1267 | C11H20 | 1،3-Nonadiene،5،5-dimethyl | 28 | ||
0.11 | 43.18 | 1280 | C9H10O2 | Vinylguaicol | 29 | ||
0.38 | 43.68 | 1287 | C10H16O | 2،4-Decadienal، (E،E) | 30 | ||
0.26 | 45.78 | 1317 | C10H16O2 | Lilac aldehyde D | 31 | ||
0.37 | 47.30 | 1339 | C11H20O | 2-Undecen-1-al | 32 | ||
0.26 | 48.18 | 1352 | C10H20O2 | n-Capric acid | 33 | ||
0.79 | 48.77 | 1360 | C13H18O | 2-Buten-1-one1-(2،6،6-trimethyl-1،3-cyclohexadien-1-yl)-، (E) | 34 | ||
0.12 | 49.31 | 1368 | C13H20 | 2-Carene،4-.alpha.-isopropenyl | 35 | ||
0.09 | 50.59 | 1387 | C13H26O | Pseudoionone hexahydro | 36 | ||
0.10 | 50.66 | 1388 | C13H26O | Tridecanal | 37 | ||
0.21 | 51.18 | 1395 | C13H20O | 6،8-Nonadien-2-one،6-methyl-5- | 38 | ||
0.42 | 53.35 | 1428 | C13H22O | Dihydropseudoionone | 39 | ||
0.36 | 55.55 | 1462 | C13H20O | beta-lonone | 40 | ||
0.17 | 57.27 | 1488 | C14H26 | cis،cis-5،9-Tetradecadiene | 41 | ||
0.20 | 57.40 | 1490 | C13H26O | Tridecanal | 42 | ||
0.67 | 60.99 | 1547 | C15H26O | trans-Nerolidol | 43 | ||
0.14 | 63.78 | 1592 | C16H32O | Hexadecanal | 44 | ||
0.18 | 67.70 | 1658 | C16H34O | 1-Decanol، 2-hexyl | 45 | ||
0.05 | 68.11 | 1665 | C15H26O | alpha.-Bisabolol | 46 | ||
0.14 | 69.84 | 1694 | C15H30O | Pentadecanal | 47 | ||
0.29 | 70.18 | 1700 | C17H36 | Heptadecane | 48 | ||
0.48 | 72.69 | 1745 | C15H30O2 | Pentadecanoic acid | 49 | ||
0.14 | 75.58 | 1796 | C16H32O | Palmitaldehyde | 50 | ||
0.13 | 75.78 | 1800 | C18H38 | Octadecane | 51 | ||
0.23 | 77.11 | 1825 | C16H22O4 | Phthalic acid، diisobutyl ester | 52 | ||
3.65 | 77.40 | 1830 | C18H36O | 2-Pentadecanone trimethyl | 53 | ||
0.10 | 79.60 | 1872 | C18H38O | Hexadecane،1-methoxy-13-methyl | 54 | ||
0.10 | 81.55 | 1909 | C17H34O2 | Hexadecanoicacid،methyl ester | 55 | ||
0.66 | 83.42 | 1945 | C18H36O2 | Octadecanoic acid | 56 | ||
0.20 | 86.23 | 2001 | C19H40O | Nonadecanol | 57 | ||
0.07 | 95.69 | 2100 | C21H44 | Heneicosane | 58 | ||
0.10 | 89.84 | 2124 | C19H32O2 | Linolenic acid، methyl ester | 59 | ||
2.92 | 91.06 | 2125 | C20H40O | Phytol | 60 | ||
2.58 | 100.52 | 2223 | C22H46 | Pentadecane، 8-heptyl | 61 | ||
0.12 | 104.42 | 2400 | C24H50 | Tetracosane | 62 | ||
1.09 | 108.53 | 2800 | C28H58 | Octacosan | 63 | ||
37.15 | 110.76 | 3100 | C31H64 | Hentriacontane | 64 | ||
0.09 | 112.47 | 3600 | C36H74 | Hexatriacontane | 65 | ||
90.77% | Total identified | ||||||
37.11 | Terpenoids | ||||||
60.66 | Non-terpenoid |
Compositions of Dichloromethane extract and its 80%, 100% potent cytotoxic Vacuum liquid chromatography fractions of S. atropatana aerial parts
Samples | Compounds | RT(a) | Area (%) |
---|---|---|---|
Neophytadiene | 27.83 | 4.59 | |
3,7,11,15-Tetramethyl-2-hexadecen-1-ol | 28.74 | 1.3 | |
n-Hexadecanoic acid | 29.98 | 4.6 | |
Menthol | 33.27 | 2.04 | |
DCM extract | 9-Octadecenoic acid | 33.52 | 2.47 |
n-Nonadecane | 40.32 | 1.47 | |
n-Octadecane | 43.49 | 3.38 | |
n-Tetratriacontane | 46.82 | 53.77 | |
Octacosane | 48.69 | 4.26 | |
Loliolide | 22.13 | 38.83 | |
80% VLC fraction | Neophytadiene | 24.76 | 32.62 |
Octadecanoic acid | 26.89 | 28.55 | |
n-Pentadecane | 11.73 | 7.24 | |
Eicosane | 16.98 | 9.58 | |
Loliolide | 22.14 | 35.27 | |
n-Heneicosane | 23.10 | 5.71 | |
100% VLC fraction | Neophytadiene | 24.77 | 9.93 |
3,7,11,15-Tetramethyl-2-hexadecen-1-ol | 25.68 | 3.47 | |
n-Hexadecanoic acid | 26.94 | 23.99 | |
Phytol | 30.23 | 1.98 | |
1,2 Benzenedicarboxylic acid, ditridecyl ester | 37.52 | 2.83 |
Assay for Total Phenolics Content (TPC)
Total phenol content was evaluated by modified Folin-ciocalteu reagent method and gallic acid as standard. Concisely, 1 mL of each total extracts (5 mg in 60% aqueous acetone) were mixed thoroughly and shacked with 2 mL of 10% Folin Ciocalteu reagent and 1 mL of 5% aqueous Na2CO3 (which was prepared by dissolving Na2CO3 in water) in a volumetric flask. Subsequently, the mixtures were centrifuged in 1200 rpm for 5 min and allowed to incubate for 30 min at 25 oC. Afterwards, absorbance of upper mixture was assessed at constant wavelength 750 nm. The same procedure was applied to different concentrations of Gallic acid solutions as a standard and calibration curve was drawn. TPC was reported as Mg gallic acid equivalent per gram of dried extract (27).
Estimating of total flavonoid contents by colorimetric assay (TFC)
Total flavonoid contents of the samples were determined by leading a modified aluminium chloride colorimetric method and also Rutin as a standard. Briefly, 2 mL of different extracts and fractions (which were prepared in 80% methanol) were mixed with 400 μL of water, 400 mg Sodium acetate, 183 mg Aluminium chloride and were kept in dark place at 25 oC for 30 min for complete reaction. In addition, the absorbance of all solutions was read at 430 nm. Rutin standard (which was prepared in 5-25 µg/mL dilutions) was applied for calibration curve quantitatively. TFC was calculated as Rutin equivalents per gram of the dried plant material (28).
Brine Shrimp Lethality Test (BSLT)
BSLT as a simple, low cost, high sensitive, and convenient pharmacologic guide was applied in a laboratory bioassay for screening general toxicity through the assessment of the 50% fatal concentration following the modified Meyer method and previous works (7). Concisely, the hatching eggs which were obtained from Fisher Center, Tabriz, Iran, were prepared in 35% salt water and incubated under well aerated, flask for 48 h. Subsequently, the different herbal extracts were dissolved in DMSO and normal saline for obtaining variable concentration of the samples. (It is worth to mention that ultimate DMSO concentration of did not overpass 0.05%). One milliliter of main prepared sample solution along with 10 mL of sea water was added to each sterile vial. In addition, approximately, 10 nauplii as amateur shrimps were transferred in to the vials and incubated for 24 h. Finally, number of dead nauplii at each dosage were counted as percent of mortality of the extracts. The LC50 was estimated using linear regression analysis by Microsoft Excel software.
Free radical scavenging activity test (FRST)
Free radical scavenging potential of all test samples was estimated using 2, 2-diphenyl-1-picrylhydrazyl (DPPH) reagent (C18H12N5O6 formula, molecular weight 394) (Sigma-Aldrich, Germany) which was adopted with slight modification (29, 30). DPPH solutions (0.08 mg/mL) for non-polar and polar extracts were prepared in chloroform and MeOH, respectively. Different concentrations of extracts and fractions (5 × 10-1, 2.5 × 10-1, 1.25 × 10-1, 6.25 × 10-2, 3.13 × 10-2 and 1.56 × 10-2 mg/mL) were obtained by serial dilutions, then mixed with 0.08 mg/mL DPPH solution. The mixtures were incubated for 30 min in 25 °C for complete reaction. The UV absorbance of all samples was measured at a constant 517 nm. The reduction of free radical capacity was calculated by the following formula:
R% = (A Blank – A Sapmle)/A Blank) × 100 (1)
Subsequently, 50% inhibition capacity value was resulted from the graph plotting reduction percentage against different concentrations of the extracts. Quercetin was used as a positive control. All of the experiments were followed in the same manner for positive control. The experiment was repeated in triplicate.
Statistical Analysis
All experiments were conducted in triplicate measurements and presented as the mean ± SD. Data were analyzed by Microsoft Excel and SigmaPlot 2010. The IC50 value was calculated from nonlinear regression analysis.
Results
In the current research, free radical scavenging activity, TPC, TFC, anti-proliferative activities and GC-MS analysis of three different extracts and also EO obtained from the aerial parts of S. atropatana were determined and the results were illustrated in Tables 1-4.
Antioxidant characteristic of the S. atropatana EO, extracts and its fractions:
The findings of antioxidant activity of the EO, extracts, and Sep-pak fractions of S. atropatana are shown in Table 1. A low cost and preliminary method to assess the free radical scavenging potency of the samples is based on a colorimetric assay. In the current assay, MeOH extract and its fractions indicated free radical scavenging activities in a concentration-dependent manner. RC50 values of MeOH extract, 40% and 20% Sep-pak fractions (0.143 ± 0.09, 0.04 ± 0.00 and 0.092 ± 0.00 mg/L, respectively) in comparison to the quercetine as a reference control (RC50 = 0.003 ± 0.00 mg/mL) indicated a moderate activities.
Total phenols content (TPC)
Total phenolic constituents were calculated quantitatively as standard gallic acid equivalents, using Folin- Ciocalteau`s method. Our findings in Table 1 illustrated that MeOH extract, 40% and 60% MeOH-Water Sep-pak fractions with (68.37 ± 0.06, 146.65 ± 2.34 and 127.52 ±0.31 mg GAE/g of samples, respectively) were superior to the phenolic content of the other extracts and fractions.
Total Flavonoids Content (TFC)
The TFC of the samples were evaluated using aluminum chloride reagent assay (Table 1). The amount of flavonoids in all samples were expressed as rutoside equivalent (as the standard flavonoid) in mg g-1 dry samples. It is notable that the TFC content of MeOH extract, 40% and 60% Sep-pak fractions (52.04 ± 0.42, 120.12 ± 2.25 and 100.23 ± 4.43 mg rutin equivalent in 1 g of dried powdered plant material, respectively) encompass the significant amount of flavonoids than the other samples.
General toxicity
Preliminary Brine Shrimp lethality bioassay was used for comparing the cytotoxic activity of the extracts with positive control (Podophyllotoxin LC50 = 2.69 µg/mL). Results illustrated that the DCM and MeOH extracts with LC50 values of 0.064 and 0.271 µg/mL respectively, showed moderate effects. In terms of n-hex extract and EO no significant effects were observed.
Cytotoxic activity
Based on the BSLT findings, the DCM and MeOH extracts of S. atropatana illustrated considerable effects in comparison to n-hex sample. So, potent samples were selected for further anti-proliferative investigations on both SW-480 and MCF-7 cell lines as the cancerous cells and L-929 as the normal cell line during 24 and 48 h period (Table 2).
Hence, MTT method was accomplished for assessing the cytotoxic activity. IC50 values for more elucidating the consequence were indicated in Table 2. Based on our previous published data against MCF-7 cell line (31), IC50 value for DCM extract against MCF-7 cell line was 223.00 and 114.70 µg/mL during 24 and 48 h. However, MeOH extract illustrated minimum growth inhibition activity on SW480 during 24 and 48 h (674.10 ± 45.30 and 557.20 ± 15.02 µg/mL) compared with DCM extract in 24 and 48 h (420.25 ± 25.15 and 390.31 ± 22.35 µg/mL), respectively. According to the results, DCM extract clarified more cytotoxic effect on both SW-480 and MCF-7 cell lines in comparison to MeOH extract at 24 and 48 h incubation. Moreover, the amount of IC50 value of DCM extract on MCF-7 cells at 24 h and 48 h was lower than SW-480 cell line. On the other hand, DCM extract revealed more remarkable cytotoxicity in a time and dose dependent manner. Beside, MCF-7 cell line was selected for further evaluation by VLC fractions of DCM extract. Among the fractions, 80% and 100% VLC fractions (with IC50 = 88.53 ± 12.85, 60.7 ± 10.79 (µg/mL), respectively), revealed considerable effects on breast cancer cell line at 48 h. Interestingly, L-929 as a normal cell line was not considerably impressed by MeOH and DCM extracts) after 24 (IC50 values > 500) and 48 h (321.49 ± 32.24 and 264.30 ± 11.32 µg/mL), respectively. This means that DCM extract and its 80%, 100% VLC fractions inhibit growth of cancer cells with no harmful effect on normal cells. No anti-proliferative activity has been observed via essential oil.
Antimicrobial activity
No antimicrobial activity of the test specimens was observed against studied microorganisms.
GC-MS results
GC-MS analysis results of essential oil and potent DCM extract, 80% and 100% VLC fractions of the aerial parts from S. atropatana have been indicated in Tables 3 and 4. Hentriacontane (37.15%) and Linalool (18.82) (as Main components of EO), n-Tetratetracontane (53.77%) (Main compound in DCM), Loliolide (38.83 and 35.27%) (As a major ingredient in 80% and 100% VLC fractions, respectively) were in high amounts in the mentioned samples.
Discussion
Colon cancer as a malignancy of the digestive system and breast cancer are the most common and prevalent types of malignancy in men and women, respectively. According to the statistics of world cancer, colon cancer is the third while breast cancer is the second most common cancers worldwide and in some cases it is associated with major mortality and morbidity. The incidence of both types of cancers is alarmingly rising both in developing and developed countries. Environmental factors play a critical role in boosting the genre of cancers (1, 2). Nowadays, because of the inefficiency of conventional therapeutic methods, numerous efforts have concentrated on finding safe constituents with high efficiency and minimum unwanted side effects, to ameliorate the various types of cancer. In this regard, the use of natural origin products with low unfavorable effect has made them high interest and the most popular tool (1, 2 and 31) in recent years.
In the current study, BSLT and FRST as valid, low cost, easily mastered laboratory bioassays, were applied to assess the toxicity and free radical effects of different extracts of S. atropatana specimen, respectively (32, 33). Although, among the extracts, the DCM and MeOH extracts of S. atropatana had considerable effects against A. salina. The non-polar extract (n-hex) and EO of plant has the lowest capability to inhibit A. salina proliferation. Subsequently, two malignant cell lines (MCF-7, SW480) and a normal cell line (L929) were applied for further evaluation of the in-vitro cytotoxic potential of potent DCM and MeOH extracts, using the MTT assay. The cytotoxic activity of samples was based on the reduction of tetrazolium MTT (yellow) to formazane dye (purple). Hence, the amount of formazan showed the number of viable cells. In our previous study, we evaluated the cytotoxic effects of different extracts of S. atropatana on the MCF-7 cell line. The MTT results showed that during 24 h, different concentrations of samples did not exert any noticeable anti-cancer effect (34). Correspondingly, after 48 h, DCM and MeOH specimens significantly increased the anti-proliferative effects on MCF-7 and showed no significant impact on the L929 normal cells, in a dose and time-dependent manner. The IC50 amount of DCM is lower than the MeOH extract. In a recent study, the anti-proliferative activity of all extracts was assessed against the SW480 cell line as well. The IC50 amounts on the SW480 in comparison to the MCF-7 cell line were high. In other words, the ability of the extracts to eliminate the colon tumor cells in comparison to breast cancer was negligible (it is worth mentioning that the DCM extract not only in the MCF-7 cell line, diminished the cancer cells but also, in the SW480 cell line it eliminated the colon cancers). It appears that the MTT results are supported by the BSLT findings. Conversely, in our present study, there is a parallel relationship between the cytotoxicity of BSLT and the MTT assay which is consistent with the reports which illustrated the direct correlation between these techniques (7). Therefore, it appears that BSLT could be an appropriate preliminary method for predicting cytotoxicity in the MCF-7 cell line in this plant. In this regard, based on the remarkable cytotoxic property of the DCM extract on the breast cancer cell line, six fractions of DCM extracts were prepared for further elucidations. It was found that, 80% and 100% fractions at 24 h and 48 h showed significant anti-tumor effects on breast cancer cells with no noticeable inhibitory impact on L929 cells.
The results revealed the accumulation of cytotoxic components in polar VLC fractions. Extra researches have illustrated the anti-proliferative activity of various species of the Scrophularia genus (7, 34-36). The findings of the present study are in line with the studies of Giessrigl B et al. (35), Asgharian P et al. (7), and Valiyari S (36). In all studies, DCM and MeOH extracts significantly suppressed the growth and replication of different cancer cells, especially the MCF-7 cells by inducing apoptosis. The preliminary phytochemical analysis of the DCM extract in our previous study, illustrated the presence of cardiac glycosides, sterols and terpenoids (7, 19). Moreover, the cytotoxic activity of the mentioned secondary metabolites has been reported by previous published papers (16, 37-39). To predict the volatile chemical constituents of the potent DCM extract and its fractions, GC-MS analysis was applied. In all samples, hydrocarbons such as n-Tetratriacontane and Loliolide were the main components which showed growth inhibition on cancerous cells in previous literatures (40-42). Moreover, in the recent study, the relationship between TPC, TFC as well as the free radical scavenging ability of different extracts of S. atropatana were evaluated. Among the extracts, the MeOH extract, 40% and 60% Sep-pak fractions demonstrated potent free radical inhibition with high amounts of phenolic contents. Although, the free radical scavenging activity of the MeOH extract was high; the anti-neoplastic activity of this extract in comparison to the DCM extract was negligible. While, the general toxicity and cytotoxic activity of the extracts were in parallel, TPC, TFC, and free radical scavenging activities of the extracts were also in line with each other.
It appears that the mechanism of cytotoxic activity of S. atropatana was different from the radical scavenging activity and total phenolic contents. In the case of the chemical constituents of EO, non-terpenoids (Hentriacontane) and terpenoids (Linalool) were in high amounts, respectively. The results were consistent with our previous published work which indicated that linalool was the main common compound in S. frigida and S. subaphylla (4, 6). The agar disk diffusion method was used to screen the anti-microbial activity of the all samples. None of the extracts and EO illustrated growth inhibition on microorganisms. The next step of the research should be concentrated on the isolation of pure anti-neoplastic compounds of potent fractions and evaluation of its anti-proliferative mechanisms.
Conclusion
Generally, the current survey proposed that the presence of some bioactive components in DCM and MeOH samples inhibit the growth of cancerous cells and also demonstrates the free radical scavenging activity with high contents of TPC and TFC in MeOH, respectively. It seems that the mechanism of cytotoxic activity of S. atropatana was different from the radical scavenging activity and total phenolic contents.
Acknowledgements
References
-
1.
HemaIswarya S, Doble M. Potential synergism of natural products in the treatment of cancer. Phytother. Res. 2006;20:239-49. [PubMed ID: 16557604].
-
2.
Koehn FE, Carter GT. The evolving role of natural products in drug discovery. Nat. Rev. Drug Discov. 2005;4:206. [PubMed ID: 15729362].
-
3.
Organization WH. WHO handbook for reporting results of cancer treatment. Geneve. 1979;48:134-230.
-
4.
Asgharian P, Afshar FH, Asnaashari S, Moghaddam SB, Ebrahimi A, Delazar A. Characterization of terpenoids in the essential oil extracted from the aerial parts of scrophularia subaphylla growing in Iran. Adv. Pharm. Bull. 2015;5:557. [PubMed ID: 26819929].
-
5.
Mozaffarian V. A dictionary of Iranian plant names: Latin, English, Persian. Farhang Mo’aser, Tehran. 1996;6:245-56.
-
6.
Asgharian P, Heshmati Afshar F, Asnaashari S, Bamdad Moghaddam S, Delazar A. The seasonal variations of the chemical composition of essential oil obtained from Scrophularia frigida. JundishapurJ. Nat. Pharm. Prod. 2016;11:e29742.
-
7.
Asgharian P, Afshar FH, Asnaashari S, Lotfipour F, Baradaran B. Evaluation of various biological activities of the aerial parts of Scrophularia frigida growing in Iran. Iran. J. Pharm. Res. 2017;16:277. [PubMed ID: 28496481].
-
8.
Delazar A, Asgharian P. Cardioprotective effects of methanolic extract of Scrophularia frigida on ischemia-reperfusion-induced injuries in isolated rat heart. Iran. J. Pharm. Res. 2017;16:35-45.
-
9.
Benito PB, Martinez MA, Sen AS, Gómez AS, Matellano LF, Contreras SS. In-vivo and in-vitro antiinflammatory activity of saikosaponins. Life Sci. 1998;63:1147-56. [PubMed ID: 9763210].
-
10.
Shen X, Eichhorn T, Greten HJ, Efferth T. Effects of Scrophularia ningpoensis Hemsl on inhibition of proliferation, apoptosis induction and NF-κB signaling of immortalized and cancer cell lines. Pharmaceuticals. 2012;5:189-208. [PubMed ID: 24288088].
-
11.
Fernandez M, Garcia M, Saenz M. Antibacterial activity of the phenolic acids fractions of scrophularia frutescens and scrophularia sambucifolia. J. Ethnopharmacol. 1996;53:11-4. [PubMed ID: 8807471].
-
12.
Tasdemir D, Brun R, Franzblau SG, Sezgin Y, Çalıs I. Evaluation of antiprotozoal and antimycobacterial activities of the resin glycosides and the other metabolites of Scrophularia cryptophila. Phytomed. 2008;15:209-15.
-
13.
Vaez H, Garjani A, Delazar A, Rameshrad M, Toutounchi N, Nikkhah E. Effect of methanolic extract of scrophularia subuphylla on ischemia and reperfusion-induced myocardial injury. Pharm. Sci. 2018;24:8-14.
-
14.
Habibi B, Majidi Z, Fekri K, Delazar A, Vaez H. Evaluation of the effect of aerial parts of scrophularia atropatana grossh total extracts on analgesic activity and morphine induced tolerance in mice. Pharm. Sci. 2018;24:80.
-
15.
Namvaran A, Fazeli M, Farajnia S, Hamidian G, Rezazadeh H. Apoptosis and caspase 3 pathway role on anti-proliferative effects of scrophularia oxysepala methanolic extract on caco-2 cells. Drug Res. 2017;67:547-52.
-
16.
Bahadori B, Eskandani M, Mieri M, Hamburger M, Nazemiyeh H. Anti-proliferative activity-guided isolation of clerodermic acid from Salvia nemorosa L: Geno/cytotoxicity and hypoxia-mediated mechanism of action. Food Chem. Toxicol. 2018;120:155-63. [PubMed ID: 29960020].
-
17.
Mojarrab M, Emami A, Delazar A, Tayarani Z. Cytotoxic properties of three isolated coumarin-hemiterpene ether derivatives from artemisia armeniaca lam. Iran. J. Pharm. Res. 2017;16:221. [PubMed ID: 28496477].
-
18.
Goodarzi S, Nateghpour M, Asgharian P, Hadjiakhoondi A, Yassa N, Tavakoli S. Antimalarial and cytotoxic activities of roots and fruits fractions of astrodaucus persicus extract. Iran. J. Basic Med. Sci. 2017;20:1318. [PubMed ID: 29238466].
-
19.
Heshmati Afshar F, Delazar A, Asnaashari S, Vaez H, Asgharian P. Screening of anti-malarial activity of different extracts obtained from three species of scrophularia growing in iran. Iran. J. Pharm. Res. 2018;17:668-76. [PubMed ID: 29881424].
-
20.
Nikkhah E, Afshar FH, Babaei H, Delazar A, Asgharian P. Evaluation of phytochemistry and some biological activities of aerial parts and seeds of scrophularia umbrosa dumort. JundishapurJ. Nat. Pharm. Prod. 2018;13:e65054.
-
21.
Nikkhah E, Heshmati Afshar F, Babaei H, Asgharian P, Delazar A. Phytochemical analysis and in-vitro bioactivity of scrophularia umbrosa rhizome (scrophulariaceae). Iran. J. Pharm. Res. 2018;17:685-694. [PubMed ID: 29881426].
-
22.
Yaripour S, Delnavazi MR, Asgharian P, Valiyari S, Tavakoli S, Nazemiyeh H. A survey on phytochemical composition and biological activity of zygophyllum fabago from Iran. Adv. Pharm. Bull. 2017;7:109. [PubMed ID: 28507944].
-
23.
Afshar FH, Asgharian P, Khodaie L, Delazar A, Lotfipour F, Baradaran B. Anti-proliferative and antimicrobial activity of methanolic extract and spe fractions of artemisia spicigera. Jundishapur J. Nat. Pharm. 2016;12:e36903.
-
24.
Delazar A, Asgharian P, Asnaashari S. Biological and phytochemical screening of eremostachys azerbaijanica rech f aerial parts. Jundishapur J. Nat. Pharm. 2017;12:234.
-
25.
Tofighi Z, Asgharian P, Goodarzi S, Hadjiakhoondi A, Ostad SN, Yassa N. Potent cytotoxic flavonoids from Iranian Securigera securidaca. Med. Chem. Res. 2014;23:1718-24.
-
26.
Asnaashari S, Delazar A, Asgharian P, Lotfipour F, Bamdad Moghaddam S, Heshmati F. In-vitro bioactivity and phytochemical screening of extracts from rhizomes of eremostachys azerbaijanica rech F growing in Iran. Iran. J. Pharm. Res. 2017;16:306-14. [PubMed ID: 28496484].
-
27.
Singleton VL, Orthofer R, Lamuela-Raventós RM. Analysis of total phenols and other oxidation substrates and antioxidants by means of folin-ciocalteu reagent. Methods Enzymol. 1999;12:152-78.
-
28.
Zhishen J, Mengcheng T, Jianming W. The determination of flavonoid contents in mulberry and their scavenging effects on superoxide radicals. Food Chem. 1999;64:555-9.
-
29.
Roshanravan N, Asgharian P, Dariushnejad H, Alamdari N, Mansoori B, Mohammadi A, Alipour Sh, Barati M, Ghavami A, Ghorbanzadeh V, Aamazadeh F, Ostadrahimi A. Eryngium billardieri induces apoptosis via bax gene expression in pancreatic cancer cells. Adv. Pharm. Bull. 2018;8:667-74. [PubMed ID: 30607339].
-
30.
Ghavimi H, Sheidaei S, Vaez H, Zolali E, Asgharian P, Hamishehkar H. Metformin-attenuated sepsis-induced oxidative damages: a novel role for metformin. Iran. J. Basic Med. Sci. 2018;21:469-75. [PubMed ID: 29922426].
-
31.
Safarzadeh E, Delazar A, Kazemi T, Orangi M, Shanehbandi D, Esnaashari S. The cytotoxic and apoptotic effects of scrophularia atropatana extracts on human breast cancer cells. Adv. Pharm. Bull. 2017;7:381. [PubMed ID: 29071220].
-
32.
Middleton P, Stewart F, Al-Qahtani S, Egan P, O’Rourke C, Abdulrahman A. Antioxidant, antibacterial activities and general toxicity of alnus glutinosa, fraxinus excelsior and papaver rhoeas. Iran. J. Pharm. Res. 2010;12:101-3.
-
33.
Peteros NP, Uy MM. Antioxidant and cytotoxic activities and phytochemical screening of four Philippine medicinal plants. J. Med. Plants Res. 2010;4:407-14.
-
34.
Qi F, Li A, Inagaki Y, Gao J, Li J, Kokudo N. Chinese herbal medicines as adjuvant treatment during chemoor radio-therapy for cancer. Biosci. Trends. 2010;4:134.
-
35.
Giessrigl B, Yazici G, Teichmann M, Kopf S, Ghassemi S, Atanasov AG. Effects of Scrophularia extracts on tumor cell proliferation, death and intravasation through lymphoendothelial cell barriers. Int. J. Oncol. 2012;40:2063-74. [PubMed ID: 22367166].
-
36.
Valiyari S, Yari S, Baradaran B. Dichloromethane and methanol extracts of Scrophularia oxysepala induces apoptosis in MCF-7 human breast cancer cells. Adv. Pharm. Bull. 2012;2:223. [PubMed ID: 24312797].
-
37.
Kim KH, Choi SU, Kim CS, Lee KR. Cytotoxic steroids from the trunk of Berberis koreana. Bioscie. Biotech. Biochem. 2012;76:825-7.
-
38.
Newman RA, Yang P, Pawlus AD, Block KI. Cardiac glycosides as novel cancer therapeutic agents. Mol. Interv. 2008;8:36. [PubMed ID: 18332483].
-
39.
Winnicka K, Bielawski K, Bielawska A. Cardiac glycosides in cancer research and cancer therapy. Acta Pol. Pharm. 2006;63:109-15. [PubMed ID: 17514873].
-
40.
Yang X, Kang MC, Lee KW, Kang SM, Lee WW, Jeon YJ. Antioxidant activity and cell protective effect of loliolide isolated from sargassum ringgoldianum subsp. coreanum. Algae. 2011;26:201-8.
-
41.
Malek SNA, Shin SK, Wahab NA, Yaacob H. Cytotoxic components of pereskia bleo (Kunth) DC (Cactaceae) leaves. Molecules. 2009;14:1713-24. [PubMed ID: 19471192].
-
42.
Manoharan S, Kaur J. Anticancer, antiviral, antidiabetic, antifungal and phytochemical constituents of medicinal plants. Am. J. PharmTech. Res. 2013;3:149-69.